BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17402955)

  • 1. Watching, waiting and uncertainty in prostate cancer.
    Bailey DE; Wallace M; Mishel MH
    J Clin Nurs; 2007 Apr; 16(4):734-41. PubMed ID: 17402955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
    Bailey DE; Wallace M
    Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The watchful waiting management option for older men with prostate cancer: state of the science.
    Wallace M; Bailey D; O'Rourke M; Galbraith M
    Oncol Nurs Forum; 2004 Nov; 31(6):1057-66. PubMed ID: 15547629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finding more meaning: the antecedents of uncertainty revisited.
    Wallace M
    J Clin Nurs; 2005 Aug; 14(7):863-8. PubMed ID: 16000100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of watchful waiting for clinically localized prostate cancer.
    Steinberg GD; Bales GT; Brendler CB
    J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
    Pickles T; Ruether JD; Weir L; Carlson L; Jakulj F;
    BJU Int; 2007 Sep; 100(3):544-51. PubMed ID: 17532857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
    Arredondo SA; Downs TM; Lubeck DP; Pasta DJ; Silva SJ; Wallace KL; Carroll PR
    J Urol; 2008 May; 179(5 Suppl):S14-8. PubMed ID: 18405740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
    Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
    Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Men's perspectives on the impact of prostate cancer: implications for oncology nurses.
    Fitch MI; Gray R; Franssen E; Johnson B
    Oncol Nurs Forum; 2000 Sep; 27(8):1255-63. PubMed ID: 11013906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived uncertainty, social support and psychological adjustment in older patients with cancer being treated with surgery.
    Lien CY; Lin HR; Kuo IT; Chen ML
    J Clin Nurs; 2009 Aug; 18(16):2311-9. PubMed ID: 19207802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
    Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
    Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living with a prostate cancer diagnosis: a qualitative 2-year follow-up.
    Jonsson A; Aus G; Berterö C
    Aging Male; 2010 Mar; 13(1):25-31. PubMed ID: 19903116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term mortality with localized prostate cancer.
    Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
    Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Watchful waiting for elderly patients with localized prostate cancer].
    Maeda O; Kakimoto K; Ono Y; Meguro N; Kinouchi T; Usami M
    Hinyokika Kiyo; 2005 Aug; 51(8):561-3. PubMed ID: 16164273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty intervention for watchful waiting in prostate cancer.
    Bailey DE; Mishel MH; Belyea M; Stewart JL; Mohler J
    Cancer Nurs; 2004; 27(5):339-46. PubMed ID: 15525860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.